Cargando…
Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
BACKGROUND: Cardiomyocyte hypertrophy is a hallmark of cardiac dysfunction in patients with aortic stenosis (AS), and can be triggered by left ventricular (LV) pressure overload in mice by aortic banding (AB). Syndecan-4 is a transmembrane heparan sulphate proteoglycan which is found increased in th...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712407/ https://www.ncbi.nlm.nih.gov/pubmed/36205855 http://dx.doi.org/10.1007/s11033-022-07985-y |
_version_ | 1784841779946717184 |
---|---|
author | Lunde, Ida G. Aronsen, J. Magnus Melleby, A. Olav Strand, Mari E. Skogestad, Jonas Bendiksen, Bård A. Ahmed, M. Shakil Sjaastad, Ivar Attramadal, Håvard Carlson, Cathrine R. Christensen, Geir |
author_facet | Lunde, Ida G. Aronsen, J. Magnus Melleby, A. Olav Strand, Mari E. Skogestad, Jonas Bendiksen, Bård A. Ahmed, M. Shakil Sjaastad, Ivar Attramadal, Håvard Carlson, Cathrine R. Christensen, Geir |
author_sort | Lunde, Ida G. |
collection | PubMed |
description | BACKGROUND: Cardiomyocyte hypertrophy is a hallmark of cardiac dysfunction in patients with aortic stenosis (AS), and can be triggered by left ventricular (LV) pressure overload in mice by aortic banding (AB). Syndecan-4 is a transmembrane heparan sulphate proteoglycan which is found increased in the myocardium of AS patients and AB mice. The role of syndecan-4 in cardiomyocyte hypertrophy is not well understood. PURPOSE OF THE STUDY: We developed mice with cardiomyocyte-specific overexpression of syndecan-4 (Sdc4-Tg) and subjected these to AB to examine the role of syndecan-4 in hypertrophy and activation of the pro-hypertrophic calcineurin-NFAT signalling pathway. METHODS AND RESULTS: Sdc4-Tg mice showed exacerbated cardiac remodelling upon AB compared to wild type (WT). At 2–6 weeks post-AB, Sdc4-Tg and WT mice showed similar hypertrophic growth, while at 20 weeks post-AB, exacerbated hypertrophy and dysfunction were evident in Sdc4-Tg mice. After cross-breeding of Sdc4-Tg mice with NFAT-luciferase reporter mice, we found increased NFAT activation in Sdc4-Tg hearts after AB. Immunoprecipitation showed that calcineurin bound to syndecan-4 in Sdc4-Tg hearts. Isolated cardiomyocytes from Sdc4-Tg mice showed alterations in Ca(2+) fluxes, suggesting that syndecan-4 regulated Ca(2+) levels, and thereby, activating the syndecan-4-calcineurin complex resulting in NFAT activation and hypertrophic growth. Similarly, primary cardiomyocyte cultures from neonatal rats showed increased calcineurin-NFAT-dependent hypertrophic growth upon viral Sdc4 overexpression. CONCLUSION: Our study of mice with cardiomyocyte-specific overexpression of Sdc4 have revealed that syndecan-4 is important for activation of the Ca(2+)-dependent calcineurin-NFAT signalling pathway, hypertrophic remodelling and dysfunction in cardiomyocytes in response to pressure overload. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11033-022-07985-y. |
format | Online Article Text |
id | pubmed-9712407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-97124072022-12-02 Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy Lunde, Ida G. Aronsen, J. Magnus Melleby, A. Olav Strand, Mari E. Skogestad, Jonas Bendiksen, Bård A. Ahmed, M. Shakil Sjaastad, Ivar Attramadal, Håvard Carlson, Cathrine R. Christensen, Geir Mol Biol Rep Original Article BACKGROUND: Cardiomyocyte hypertrophy is a hallmark of cardiac dysfunction in patients with aortic stenosis (AS), and can be triggered by left ventricular (LV) pressure overload in mice by aortic banding (AB). Syndecan-4 is a transmembrane heparan sulphate proteoglycan which is found increased in the myocardium of AS patients and AB mice. The role of syndecan-4 in cardiomyocyte hypertrophy is not well understood. PURPOSE OF THE STUDY: We developed mice with cardiomyocyte-specific overexpression of syndecan-4 (Sdc4-Tg) and subjected these to AB to examine the role of syndecan-4 in hypertrophy and activation of the pro-hypertrophic calcineurin-NFAT signalling pathway. METHODS AND RESULTS: Sdc4-Tg mice showed exacerbated cardiac remodelling upon AB compared to wild type (WT). At 2–6 weeks post-AB, Sdc4-Tg and WT mice showed similar hypertrophic growth, while at 20 weeks post-AB, exacerbated hypertrophy and dysfunction were evident in Sdc4-Tg mice. After cross-breeding of Sdc4-Tg mice with NFAT-luciferase reporter mice, we found increased NFAT activation in Sdc4-Tg hearts after AB. Immunoprecipitation showed that calcineurin bound to syndecan-4 in Sdc4-Tg hearts. Isolated cardiomyocytes from Sdc4-Tg mice showed alterations in Ca(2+) fluxes, suggesting that syndecan-4 regulated Ca(2+) levels, and thereby, activating the syndecan-4-calcineurin complex resulting in NFAT activation and hypertrophic growth. Similarly, primary cardiomyocyte cultures from neonatal rats showed increased calcineurin-NFAT-dependent hypertrophic growth upon viral Sdc4 overexpression. CONCLUSION: Our study of mice with cardiomyocyte-specific overexpression of Sdc4 have revealed that syndecan-4 is important for activation of the Ca(2+)-dependent calcineurin-NFAT signalling pathway, hypertrophic remodelling and dysfunction in cardiomyocytes in response to pressure overload. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11033-022-07985-y. Springer Netherlands 2022-10-07 2022 /pmc/articles/PMC9712407/ /pubmed/36205855 http://dx.doi.org/10.1007/s11033-022-07985-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Lunde, Ida G. Aronsen, J. Magnus Melleby, A. Olav Strand, Mari E. Skogestad, Jonas Bendiksen, Bård A. Ahmed, M. Shakil Sjaastad, Ivar Attramadal, Håvard Carlson, Cathrine R. Christensen, Geir Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy |
title | Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy |
title_full | Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy |
title_fullStr | Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy |
title_full_unstemmed | Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy |
title_short | Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy |
title_sort | cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-nfat signalling and exacerbated cardiac hypertrophy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712407/ https://www.ncbi.nlm.nih.gov/pubmed/36205855 http://dx.doi.org/10.1007/s11033-022-07985-y |
work_keys_str_mv | AT lundeidag cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT aronsenjmagnus cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT mellebyaolav cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT strandmarie cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT skogestadjonas cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT bendiksenbarda cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT ahmedmshakil cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT sjaastadivar cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT attramadalhavard cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT carlsoncathriner cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy AT christensengeir cardiomyocytespecificoverexpressionofsyndecan4inmiceresultsinactivationofcalcineurinnfatsignallingandexacerbatedcardiachypertrophy |